KLOW 80mg

KLOW 80 mg — Blend Overview

KLOW is a four-component blend containing GHK-Cu, BPC-157, full-length thymosin beta-4, listed as TB-500, and KPV. The formulation combines 50 mg of GHK-Cu with 10 mg of each remaining component, giving a total declared compound content of 80 mg.

KLOW is the formulation name rather than the name of a single chemical substance. Its composition is described through the individual ingredients, their quantities and their respective chemical identifiers.

Structure and Composition

The four components have different peptide structures. GHK-Cu contains the three-amino-acid sequence glycine–histidine–lysine coordinated with copper. BPC-157 contains 15 amino acid residues, while full-length thymosin beta-4 contains 43.

KPV is a tripeptide comprising lysine, proline and valine. Its abbreviation comes from the single-letter codes for those amino acids: K, P and V.

The listed quantities give a mass ratio of 5:1:1:1, in the order GHK-Cu, BPC-157, TB-500 and KPV. This describes their relative weights, rather than equal numbers of molecules. The formulation combines separate compounds without creating a new peptide sequence.

KLOW Compound Information

Component	Listed amount	Chemical identity	CAS number
GHK-Cu	50 mg	Copper–tripeptide complex	89030-95-5
BPC-157	10 mg	Synthetic 15-residue peptide	137525-51-0
TB-500	10 mg	Full-length thymosin beta-4	77591-33-4
KPV	10 mg	Lys-Pro-Val tripeptide, free-acid form	67727-97-3

Blend property	Details
Product name	KLOW 80 mg
Classification	Peptide and copper–peptide blend
Number of components	4
Total declared compound content	80 mg
Component mass ratio	5:1:1:1 — GHK-Cu:BPC-157:TB-500
CAS identification	Listed separately for each component
Molecular formula	Separate formula for each component
Molecular weight	Separate molecular weight for each component

Understanding Compound Specifications

The 80 mg designation represents the combined declared amounts of the four named compounds. It does not describe a single molecular weight or necessarily the total powder weight if other formulation ingredients are present.

Each CAS number identifies the corresponding reference compound. Salt forms and terminal modifications should be distinguished in the specifications; for example, KPV with a free-acid terminus has a different chemical identity from an amidated version.

A blend’s composition and analytical purity describe different characteristics. Composition identifies the ingredients and their amounts, while analytical testing examines defined properties of the sample. A single purity percentage does not explain how each component was identified or measured.

Studies and Additional Info

• https://pmc.ncbi.nlm.nih.gov/articles/PMC6073405/
• https://pmc.ncbi.nlm.nih.gov/articles/PMC12313605/
• https://pmc.ncbi.nlm.nih.gov/articles/PMC8228050/
• https://pmc.ncbi.nlm.nih.gov/articles/PMC2431115/

Disclaimer: Vicorpus does not endorse or promote the use of SARMs or Peptides for human consumption. Our product descriptions are intended for informational purposes only and address common inquiries found on various forums. The sale of SARMs and Peptides is strictly limited to researchers for scientific and research purposes.